Nitin Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
- Paid Up Capital ₹ 23.41 Cr
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
- Satisfied Charges ₹ 4.27 Cr
- Revenue Growth -36.46%
- Profit Growth -80.38%
- Ebitda -78.27%
- Net Worth -28.43%
- Total Assets -31.92%
About Nitin Lifesciences
Nitin Lifesciences Limited (NLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 03 March 2005 and has a history of 19 years and 11 months. Its registered office is in Sirmaur, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 23.41 Cr.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹4.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Nitin Lifesciences Limited India are Pradhyuman Yadav as COMPANY SECRETARY and Subhadeep Pal as Cfo. Abhinav Arora, Sanjay Khurana, Shubhangi Agarwal, and Two other members serve as directors at the Company.
Company Details
- Location
Sirmaur, Himachal Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100HP2005PLC028049
- Company No.
028049
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2005
- Date of AGM
14 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
What products or services does Nitin Lifesciences Limited offer?
Nitin Lifesciences Limited offers a wide range of products and services, including Antibacterial Drugs, Doxycycline Injection, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Common Disease Medicines, Injectable Products, Pain Relief Drugs & Pharmaceuticals, Anesthetic, Pharmaceutical Injectables, Anti Inflammatory Drugs.
Who are the key members and board of directors at Nitin Lifesciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pradhyuman Yadav | Company Secretary | 22-Mar-2024 | Current |
| Subhadeep Pal | CFO | 21-Feb-2024 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhinav Arora  | Director | 27-Sep-2023 | Current |
| Sanjay Khurana | Director | 27-Sep-2023 | Current |
| Shubhangi Agarwal | Director | 27-Sep-2023 | Current |
| Vishal Gupta | Director | 27-Sep-2023 | Current |
| Suresh Ganachari | Director | 22-Mar-2024 | Current |
Financial Performance of Nitin Lifesciences.
Nitin Lifesciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.46% decrease. The company also saw a substantial fall in profitability, with a 80.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 28.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nitin Lifesciences?
In 2023, Nitin Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Recipharm Pharmaservices Private LimitedSuresh Ganachari is a mutual person
Recipharm Lifesciences India Private LimitedSuresh Ganachari is a mutual person
Recipharm Holding India Private LimitedSuresh Ganachari is a mutual person
Qualitek Labs LimitedShubhangi Agarwal is a mutual person
Credent Global Finance LimitedShubhangi Agarwal is a mutual person
Omniactive Health Technologies LimitedVishal Gupta is a mutual person
Charges (Loans)
₹0.50 Cr
₹4.27 Cr
Charges Breakdown by Lending Institutions
- Others : 0.30 Cr
- Haryana Financial Corporation : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Apr 2018 | Others | ₹3.00 M | Open |
| 15 Jul 1994 | Haryana Financial Corporation | ₹2.00 M | Open |
| 30 Mar 2013 | Daimler Financial Services India Private Limited | ₹2.00 M | Satisfied |
| 11 Feb 2008 | Director Of Industries Of Himachal Pradesh | ₹3.00 M | Satisfied |
| 30 Mar 2006 | State Bank Of India | ₹0.87 M | Satisfied |
How Many Employees Work at Nitin Lifesciences?
Nitin Lifesciences has a workforce of 291 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nitin Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nitin Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
